Biomechanical networks of the pre-metastatic niche: Decoding biophysical determinants of tumor metastatic organotropism.
1/5 보강
In the metastatic cascade, biomechanics acts as an invisible engine that drives tumor malignancy.
APA
Guo Z, Liu J, et al. (2025). Biomechanical networks of the pre-metastatic niche: Decoding biophysical determinants of tumor metastatic organotropism.. Cancer letters, 635, 218102. https://doi.org/10.1016/j.canlet.2025.218102
MLA
Guo Z, et al.. "Biomechanical networks of the pre-metastatic niche: Decoding biophysical determinants of tumor metastatic organotropism.." Cancer letters, vol. 635, 2025, pp. 218102.
PMID
41167581 ↗
Abstract 한글 요약
In the metastatic cascade, biomechanics acts as an invisible engine that drives tumor malignancy. Shaping the intrinsic mechanical microenvironment of cancer cells facilitates their distant colonization and metastasis. Mechanical cues serve as physical fingerprints that orchestrate the formation of a pre-metastatic niche (PMN), which is a critical bottleneck in metastasis. However, biomechanically oriented antitumor strategies that integrate the physicochemical interactions of tumor metastasis remain underexplored in clinical therapy. In this review, we examine the role of biomechanics in shaping the PMN and propose a two-phase model of its evolution: mechanotransductive priming and mechanical niche reconstruction. Furthermore, we clarify the role of biomechanics in tumor organotropism and the impact of anatomical differences among organs on metastasis. In conclusion, a deeper understanding of the biomechanical dimensions of the PMN may inform the development of novel biomechanical interventions to prevent and control tumor metastasis.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Discovery of novel and potent 2-aminopyrazine-based HPK1 inhibitors enhancing T-cell immunity against cancer.
- RASGEF1B suppresses hepatocellular carcinoma through the ALDH7A1/Betaine/SNAI1 metabolic‒epigenetic axis.
- Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.
- The microbial metabolite I3A inhibits ferroptosis and the effectiveness of redox-based cancer therapy.
- Correction: Guo et al. Shikonin as a WT1 Inhibitor Promotes Promyeloid Leukemia Cell Differentiation. 2022, , 8264.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.